His research interests include sepsis, traumatic brain injury, neurocritical care, and extra-corporeal membrane oxygenation.

He is passionate about supporting trainees/early-career clinician-scientists, and increasing diversity in clinical research. Andrew is Vice-Chair of the Australian and New Zealand Intensive Care Society (ANZICS) - Clinical Trials Group (CTG), and is a proud product of Aotearoa New Zealand.

He is the co-clinical leader at Wellington Hospital ICU, the Medical Director at Wakefield Hospital Private ICU, and the Deputy Director at the Medical Research Institute of New Zealand. He is an adjunct professor (Research) at Monash University and a Clinical Associate Professor in Critical Care at the University of Melbourne. He has published more than 250 manuscripts in peer-reviewed journals. His research interests include everything related to critical illness and intensive care. He is involved in research collaborations with investigators from around the world.

He is a NHMRC Research Fellow (EL2) with research interests in anaemia and recovery after ICU, sepsis and the microbiome, cardiac surgery, sleep, and novel trial designs. He is a board director of the Intensive Care Foundation and Clinical Director of the ANZICS Critical Care Resources Registry. Prof Litton has received over $12M AUD in competitive grant funding as Chief Investigator and has published more than 150 manuscripts in the peer review literature.

Kimberley is also the Physiotherapy Research Lead and Senior Critical Care Physiotherapist at Western Health, Melbourne, Victoria. She is an international leader in the field of critical care survivorship with methodological expertise in patient and family engagement, co-design, and qualitative research in vulnerable cohorts. She currently leads the icuRESOLVE research program that is focused on advancing the science of peer support and post-ICU care. Associate Professor Haines holds several leadership positions including as an executive member of the ANZICS Clinical Trials Group, Co-Chair of the ANZICS Patient and Family Engagement Working Group, and she serves on other international committees including for the American Thoracic Society Critical Care Assembly.

He is currently a Professorial Fellow in the Division of Critical Care at the George Institute for Global Health, also holding appointments as Associate Professor at Sydney Medical School, University of Sydney and an adjunct Senior Research Fellow at the Australian and New Zealand Intensive Care Research Centre, in the Department of Epidemiology and Preventative Health at Monash University. He maintains a clinical role as Senior Staff Specialist in the Malcolm Fisher Department of Intensive Care Medicine at The Royal North Shore Hospital.

Associate Professor Delaney’s major research interests are centred on improving methods of resuscitation of patients with sepsis and septic shock and improving outcomes for patients suffering acute severe brain injuries.

Naomi holds several other appointments including NHMRC Emerging Leader Fellow; Conjoint Associate Professor at the Faculty of Medicine, University of New South Wales; an Editorial Board Member for Australian Critical Care Journal; Chair of the Australian Critical Care Nurses Research Advisory Panel; and Senior Research Fellow with the Australian Sepsis Network.

Naomi is a clinical nurse researcher and has led a program of sepsis research through international collaborations including facilitating 4 clinical trials in COVID-19 in India. She leads the Australian and New Zealand Intensive Care Society Point Prevalence program. She has also undertaken international point prevalence studies including a large epidemiological study of patients with sepsis in Indian ICUs. Called the SIPS (Sepsis in India Prevalence) study, it has provided vital insights into changing epidemiology with different sepsis definitions, bacteriology, and antimicrobial resistance patterns.

She is an NHMRC Emerging Leader Fellow whose research focuses on long-term follow-up of patients, evaluating the costs of care in critical illness and conducting economic evaluations alongside clinical trials in critical care. Lisa has authored over 100 publications (including in the New England Journal of Medicine and JAMA), and has received over $50 million in competitive grant funding. Lisa is a member of the Australasian Clinical Trials Alliance’s (ACTA) Health Economics alongside Trials (HEAT) group and was a key member of ACTA’s Research Prioritisation Reference Group. She also serves on the Victorian ECMO Service’s Strategic Research Working Group and was a member of the ANZICS CORE Patient Reported Outcomes and Experience Measures Working Party.

Alex holds a PhD from the school of medicine at Adelaide University for research of blood glucose control in critically ill patients with Type 2 diabetes, which received a dean’s commendation for excellence. He is interested in gastrointestinal and metabolic function during critical illness. He has been a Research and Project Manager of critical care research projects and programs with studies published in high impact journals.

Alex also has a keen interest in translating research in to practice and has working in evidence synthesis as a methods chair and senior evidence officer with the National Clinical Evidence Taskforce at Monash University part of the team producing both the COVID-19 and MPX guidelines.

She is an NHMRC Emerging Leadership Fellow with a research focus on interventions to improve blood product use in critical care, trauma and haematology. Prof McQuilten has an international profile as a leader in transfusion supportive care, and expertise in immunoglobulin use for infection prevention in haematologic malignancies.

Manoj’s research interest is in large-scale clinical trials that provide robust and reliable patient-centred evidence on thermoregulation and circulatory management in patients with acute serious illness requiring invasive organ support. He has completed a PhD and NHMRC Early Career fellowship on Thermoregulation for Acute Critical illness, including sepsis and acute brain injury.

Additionally, he achieved a second PhD at the University of Amsterdam, graduating cum laude in the fields of Intensive Care and Anesthesiology. In 2019, Ary became Associate Professor in the Division of Pulmonology at University of São Paulo and attained the status of Full Professor at the Albert Einstein Graduate School of Health Sciences. Presently, Ary holds the position of Senior Research Fellow at the Australian and New Zealand Intensive Care-Research Centre (ANZIC-RC) at Monash University, and serves as an Intensivist at Austin Health. Ary Serpa Neto is an investigator and epidemiologist involved in numerous international multicenter clinical trials, including SODa-BIC, TEAM, PReVENT, PROBESE, RELAx, and ACTiVE trials.

Dr Eastwood was the Chief Principal Investigator of the NEJM published Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest randomised controlled trial (TAME Cardiac Arrest Trial). He holds a Research Doctorate (PhD) with Deakin University in research dedicated to oxygen therapy for patients at risk of respiratory dysfunction. His research program is focused on the impact and outcome of gas management (oxygen and carbon dioxide) in critically ill patients and he has published widely in this area.

He has completed a Doctor of Medicine in aspects of the Rapid Response Team (RRT). He has also completed a PhD on the RRT that assessed the characteristics and outcomes of patient who are reviewed by the RRT, and details of resource utilization of the MET in ICU-equipped hospitals throughout Australia.

Daryl is the medical director of critical care outreach at the Austin Hospital and is the immediate past president of the international society for Rapid Response Systems. His major research interest is in the recognition of, and response to clinical deterioration, particularly during sepsis in the emergency department and hospital wards.

Shekar is passionate about addressing the global variability in intensive care and extracorporeal life support (ECLS) outcomes through innovation, research, and education. His research interests include pathophysiology of cardiorespiratory failure and ECLS. His ongoing research program “The No Tube Project” aims to integrate less invasive respiratory supports with ECLS to provide more personalized respiratory support and to minimise the burden of invasive mechanical ventilation.

Shekar is an active contributor to the Extracorporeal Life Support Organisation (ELSO) through his research and educational engagements. He is a member of the Asia-Pacific ELSO Education Committee and is the Course Director of an ELSO endorsed ECMO course. He is the research lead for ELSO Education Taskforce (ELSOed) and as a member of the scientific committee of the International ECMO Network, he contributes to global collaborative research in ECMO.

She holds a Doctor of Philosophy and Master of Public Health from the

School of Population Health within the Faculty of Medicine at UNSW,

Sydney. She is a Registered Nurse, with a Bachelor of Nursing from the

University of Newcastle, with clinical experience in intensive care.

Kelly’s primary research interest is in health and gender equity in the

clinical area of infection and sepsis. She uses population level data to

understand and improve equity in health outcomes for survivors of sepsis

and critical illness.

He has considerable interest in clinical trials and outcomes from critical illness. He is also a Principal Research Fellow in Intensive Care with the University of Melbourne, where he is the Clinical Lead for the MISCH Clinical Trials Node Adam is the Postgraduate Coordinator for the Department of Critical Care He holds a Career Development Fellowship with the National Health and Medical Research Council (NHMRC) and was the top-ranked applicant in the 2017 Level 2 (Clinical) round.

He is also Director of Intensive Care Research at the Austin Hospital and Senior Research Advisor in Intensive Care Research at the Royal Melbourne Hospital. He has produced >1800 PubMed cited publications, is the most published biomedical investigator in the history of Australian medicine and the most published intensive care investigator in the world.

In 2017, he was awarded an Officer of the Order of Australia (AO) for distinguished service to intensive care medicine in the field of traumatic brain injury as a clinician, and to medical education as an academic, researcher and author. In 2021, he was jointly awarded the Research Australia GSK Award for Research Excellence in recognition of his global leadership and innovative research in critical care medicine that has helped transform approaches to the treatment of critically ill patients worldwide. He has >400 publications including 18 in NEJM, Lancet, and JAMA. He has peer reviewed research grants exceeding $91M including 45 NHMRC/MRFF grants.

She has held NHMRC or Heart Foundation funding throughout her career, currently with an Investigator Grant (2020-2024). She is a Specialist Physiotherapist in Intensive Care at The Alfred Hospital, Melbourne, Australia. She is a Fellow of the Australian Academy of Health and Medical Science and of the Australian College of Physiotherapists. She has expertise in rehabilitation and long-term outcomes of critically ill patients, and the use of invasive life support such as mechanical ventilation and extracorporeal membrane oxygenation (ECMO).

He is a past-Chair of the ANZICS Clinical Trials Group.

He has been an investigator on trials with an accumulated sample size of more than 60,000 patients, is a named investigator on more than $150 M of competitive research funding and has published more than 250 manuscripts, including multiple manuscripts in NEJM (11) and JAMA (12), that have been cited more than 60,000 times. He has experience with Bayesian adaptive platform trials and other innovative designs such as cluster cross-over trials. He was the global leader of the REMAP-CAP platform trial that reported the treatment effect of 15 different interventions for patients with severe COVID-19 infection. Results from his trials have been incorporated rapidly into international guidelines and implemented into clinical practice saving many lives.

His vision is that research will be purpose driven for impact, focusing on generating and implementing evidence that will improve patient outcomes and performance of the healthcare sector.

Besides his clinical duties, A/Prof Cohen is an established researcher in the field of critical care endocrinology. He has authored numerous research articles in the field of adrenal function in critical illness and is a CI on the NHMRC funded ADRENAL trial, an international multi-centre trial. His work has focussed on the measurement of adrenal function and mechanisms of glucocorticoid resistance in septic shock and has led numerous publications in this and related areas. He is currently an Associate Professor in the University of Queensland, an Honorary Professorial Fellow at The George Institute, and an elected member of the Board of the College of Intensive Care Medicine.

Jacob is a psychology academic specialising in the psychological and behavioural impacts of trauma, critical illness, and healthcare‑associated adversity. His work spans critical care recovery, post‑sepsis outcomes, and trauma‑informed healthcare, with a focus on improving safety, quality, and patient‑centred outcomes across the health system.

Drawing on both professional expertise and lived experience as a sepsis survivor, Dr Dye bridges research, healthcare evaluation, and policy. He has contributed to major NHMRC‑, MRFF‑, and VicHealth‑funded programs, including national sepsis clinical trials and research redesigning post‑discharge models of care across the lifespan. Through his research leadership and advisory roles, he works with clinicians, policymakers, hospitals, and government agencies to embed trauma‑informed, evidence‑based, and lived‑experience‑led approaches into sepsis, delirium, and critical care recovery frameworks.

She is the Immediate Past Chair of the ANZICS CTG Executive Committee. She was Chair of the Management Committee for the NHMRC-funded, ANZICS CTG-endorsed Australasian Resuscitation In Sepsis Evaluation (ARISE) multi-centre trial of early resuscitation in sepsis and co-Chair of the Management Committee for the NHMRC-funded, CTG-endorsed multi-centre TARGET trial. She is currently Chief Investigator of the NHMRC-funded, CTG-endorsed multi-centre ARISE-Fluids Trial.

His interests include ICU outcome monitoring, severity of illness assessment, organ donation, lung transplantation, ECMO and ICU informatics research.

He has co-authored 350 publications, six book chapters, supervised nine PhD students and received over $25 million in competitive and government grants since 2000 but what he really enjoys doing when not in the ICU, is burying himself deep in data with biostatisticians, data scientists and clinicians.

Simon was a founding member and is a past-Chair of the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group, is a past chair of the International Sepsis Forum, and past Vice President of the Global Sepsis Alliance. He is the Director of Sepsis Australia and the Asia Pacific Sepsis Alliance.

A Fellow of the Australian Academy of Health and Medical Sciences, Simon was appointed an Officer (AO) in the Order of Australia in the Queen’s Birthday Honours List 2020 for “distinguished service to intensive care medicine, to medical research and education, and to global health institutes”

She has experience coordinating primary endpoints for the ASPirin in Reducing Events in the Elderly (ASPREE XT) trial and holds a First-Class Honours in the field of Cardiovascular Pharmacology at Monash University. Rose studied a Bachelor of Pharmacy at Heinrich Heine University, Germany.